Bromocriptine therapy in eleven patients with acromegaly.
L. Lundin, Sverker Ljunghall, Leif Wide, Henrik Boström
Abstract
L. Lundin, Sverker Ljunghall, Leif Wide, Henrik Boström
Abstract
Eleven patients with active acromegaly were treated with bromocriptine for one year or more. Nine showed significant reduction in plasma growth hormone levels and eight improvement with respect to clinical symptoms. No serious side effects were observed.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Eleven patients with active acromegaly were treated with bromocriptine for one year or more. Nine showed significant reduction in plasma growth hormone levels and eight improvement with respect to clinical symptoms. No serious side effects were observed.
Key concepts: Bromocriptine, Acromegaly, Medicine, Internal medicine, Endocrinology, Growth hormone, Hormone, Prolactin